WATCHMAN, a Long-Term Growth Driver: Boston Scientific’s structural heart programs are fast building momentum, banking on a strong performance of the WATCHMAN left atrial appendage closure device.

Have you been paying attention to shares of Boston Scientific (BSX)? Shares have been on the move with the stock up 2% over the past month. The stock hit a new 52-week high of $92.42 in the ...

In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...

Boston Scientific’s BSX robust expansion of operations ... The company’s Electrophysiology (EP) arm continues to gain momentum on the sustained adoption of FARAPULSE PFA.